CN102188517A - Traditional Chinese medicine for treating hyperosteogeny - Google Patents
Traditional Chinese medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN102188517A CN102188517A CN2011100683461A CN201110068346A CN102188517A CN 102188517 A CN102188517 A CN 102188517A CN 2011100683461 A CN2011100683461 A CN 2011100683461A CN 201110068346 A CN201110068346 A CN 201110068346A CN 102188517 A CN102188517 A CN 102188517A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- hyperosteogeny
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating hyperosteogeny, comprising the following components in parts by weight: 30 parts of white paeony root, 12 parts of liquorice, 15 parts of caulis spatholobi and 15 parts of radix clematidis. If patients get diarrhea, 10-20 parts of atractylodes macrocephala and 8-15 parts of Tuckahoe can be added. The invention has functions of diminishing inflammation, relieving rheumatism, softening bone spurs, clearing and activating channels and collaterals and treating both symptoms and root causes, and can be widely used in orally taken traditional Chinese medicines for treating hyperosteogeny.
Description
Technical field
The invention belongs to the field of Chinese medicines, specifically be meant a kind of Chinese medicine for the treatment of hyperosteogeny.
Background technology
Bone matrix hyperplasia is called hyperplastic osteoarthritis, osteoarthritis, degenerated arthrosis, senile arthritis, hypertrophiarthritis again, be because soft tissue degeneration, degenerations such as the cartilage in formation joint, intervertebral disc, ligaments, the edge, joint forms bony spur, variations such as synovial membrane plumpness, and osteoclasia appears, cause insecondary hyperosteogeny, cause joint deformity, when being subjected to abnormal load, cause arthralgia, a kind of disease of symptoms such as limitation of activity.Divide two kinds of constitutional and Secondary cases.The pathology aspect shows as irregular cartilage infringement, subchondral bone sclerosis, cyst in the zone of bearing a heavy burden, and the edge osteophytosis, the metaphysis blood flow increases and synovitis in various degree.
The present Therapeutic Method of hyperosteogeny, it is main that doctor trained in Western medicine mainly adopts operation, Drug therapy is auxilliary, but the operation meeting brings misery to patient, and patient's postoperative needs the bed of long period to recover, and the recurrence probability is higher; The traditional Chinese medical science also has some medicines and method, but the time is longer, and cure rate is low.
Summary of the invention
In order to overcome the defective of above-mentioned prior art, the invention discloses a kind of Chinese medicine for the treatment of hyperosteogeny, it is characterized in that, comprise Radix Paeoniae Alba 30-60 part, Fructus Chaenomelis 8-15 part, Radix Glycyrrhizae 8-15 part, Caulis Spatholobi 10-20 part, Radix Clematidis 10-20 part by weight.
Optimized technical scheme provided by the invention is: comprise 30 parts of the Radix Paeoniae Albas, 12 parts of Fructus Chaenomeliss, 12 parts in Radix Glycyrrhizae, 15 parts of Caulis Spatholobis, 15 parts of Radix Clematidis by weight.
Other optimal technical scheme provided by the invention is: if diarrhoea is arranged, can add Rhizoma Atractylodis Macrocephalae (parched) 10-20 part, Poria 8-15 part.
Beneficial effect of the present invention is: the present invention has the effect of antiinflammatory, dehumidifying cold expelling, softening bony spur, dredge the meridian passage, treating both the principal and secondary aspects of a disease, can be widely used in the Chinese medicine for oral administration of treatment hyperosteogeny.
The specific embodiment
Embodiment 1:
Get 30 parts of the Radix Paeoniae Albas, 12 parts of Fructus Chaenomeliss, 12 parts in Radix Glycyrrhizae, 15 parts of Caulis Spatholobis, 15 parts of Radix Clematidis by weight, be decocted in water for oral dose, day potion if diarrhoea is arranged, can add 15 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 12 parts in Poria.The present invention reuses the Radix Paeoniae Alba, if DeGrain can increase to 60 parts gradually.
Embodiment 2:
Get 40 parts of the Radix Paeoniae Albas, 8 parts of Fructus Chaenomeliss, 8 parts in Radix Glycyrrhizae, 15 parts of Caulis Spatholobis, 20 parts of Radix Clematidis by weight, be decocted in water for oral dose, day potion if diarrhoea is arranged, can add 10 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 15 parts in Poria.
Embodiment 3:
Get 50 parts of the Radix Paeoniae Albas, 15 parts of Fructus Chaenomeliss, 15 parts in Radix Glycyrrhizae, 10 parts of Caulis Spatholobis, 10 parts of Radix Clematidis by weight, be decocted in water for oral dose, day potion if diarrhoea is arranged, can add 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 8 parts in Poria.
The foregoing description only is used for further specifying the present invention, rather than limits the invention.
Claims (3)
1. a Chinese medicine for the treatment of hyperosteogeny is characterized in that, comprises Radix Paeoniae Alba 30-60 part, Fructus Chaenomelis 8-15 part, Radix Glycyrrhizae 8-15 part, Caulis Spatholobi 10-20 part, Radix Clematidis 10-20 part by weight.
2. a kind of Chinese medicine for the treatment of hyperosteogeny according to claim 1 is characterized in that, comprises 30 parts of the Radix Paeoniae Albas, 12 parts of Fructus Chaenomeliss, 12 parts in Radix Glycyrrhizae, 15 parts of Caulis Spatholobis, 15 parts of Radix Clematidis by weight.
3. a kind of Chinese medicine for the treatment of hyperosteogeny according to claim 1 is characterized in that, also comprises Rhizoma Atractylodis Macrocephalae (parched) 10-20 part, Poria 8-15 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100683461A CN102188517A (en) | 2011-03-22 | 2011-03-22 | Traditional Chinese medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100683461A CN102188517A (en) | 2011-03-22 | 2011-03-22 | Traditional Chinese medicine for treating hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102188517A true CN102188517A (en) | 2011-09-21 |
Family
ID=44597952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100683461A Pending CN102188517A (en) | 2011-03-22 | 2011-03-22 | Traditional Chinese medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102188517A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526407A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicine for treating thoracic vertebra osteoproliferation |
| CN104887778A (en) * | 2015-06-18 | 2015-09-09 | 孙太辉 | Medicine for treating hyperostosis and preparation method of medicine |
| CN105012431A (en) * | 2015-07-30 | 2015-11-04 | 成都市飞龙水处理技术研究所 | Decoction medicine for treating hyperosteogeny and preparation method thereof |
| CN109432352A (en) * | 2018-11-20 | 2019-03-08 | 威海千棠生物科技有限公司 | For treating the Chinese medicine composition and method of spur |
-
2011
- 2011-03-22 CN CN2011100683461A patent/CN102188517A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526407A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicine for treating thoracic vertebra osteoproliferation |
| CN104887778A (en) * | 2015-06-18 | 2015-09-09 | 孙太辉 | Medicine for treating hyperostosis and preparation method of medicine |
| CN105012431A (en) * | 2015-07-30 | 2015-11-04 | 成都市飞龙水处理技术研究所 | Decoction medicine for treating hyperosteogeny and preparation method thereof |
| CN109432352A (en) * | 2018-11-20 | 2019-03-08 | 威海千棠生物科技有限公司 | For treating the Chinese medicine composition and method of spur |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102961531B (en) | Chinese medicament for treating neck, shoulder, waist and leg pains and hyperostosis | |
| CN103006951B (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN101954062A (en) | Medicament for treating chronic pharyngitis | |
| CN102920876B (en) | External-application Chinese medicinal composition for treating knee osteoarthritis | |
| CN102188517A (en) | Traditional Chinese medicine for treating hyperosteogeny | |
| CN103479837B (en) | External medicine for curing hyperosteogeny and preparation method thereof | |
| CN102188538A (en) | Chinese medicine for treating hyperosteogeny of cervical vertebra and lumbar vertebrae | |
| CN102552705B (en) | Traditional Chinese medicinal capsule for treating lumbar disc herniation and femoral head necrosis | |
| CN101181488A (en) | Chinese medicine composition orally taken for curing osteosporosis | |
| CN102755571A (en) | Medicinal liquor and preparation process for treating rheumatism and rheumatoid | |
| CN101954061B (en) | Medicine for treating chronic laryngitis | |
| CN105362980A (en) | Traditional Chinese medicine composition treating gout | |
| CN104173727A (en) | Medicine for treating toothache | |
| CN104013939A (en) | Traditional Chinese medicine oral solution for treating scapulohumeral periarthritis | |
| CN104013813A (en) | Pharmaceutical composition for treating acute diarrhea | |
| CN103735756A (en) | Traditional Chinese medicinal prescription for treating low back and leg pain | |
| CN103610831B (en) | A kind of Chinese medicine for the treatment of neck and shoulder pain | |
| CN103127458A (en) | Drug for treating osteoarticular myalgia | |
| CN105687912A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN100556434C (en) | Prostatitic medicine of a kind of treatment and preparation method thereof | |
| CN112402584A (en) | Chinese and western medicine compound medicine for treating osteoarthritis and preparation method thereof | |
| CN103751735A (en) | External use powder for treating rheumatism | |
| CN104606396B (en) | A kind of medicine for treating epiphysis osteochondritis and preparation method thereof | |
| CN103599296B (en) | A kind of Chinese medicine for the treatment of prolapse of lumbar intervertebral disc | |
| CN103536822B (en) | The medicine for the treatment of hyperosteogeny and prolapse of lumbar intervertebral disc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110921 |